Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study
- PMID: 21996169
- DOI: 10.1016/S1470-2045(11)70250-9
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study
Abstract
Background: The natural history of screen-detected breast cancers is not well understood. A previous analysis of the incidence change during the introduction of the Norwegian screening programme in the late 1990s suggested that the natural history of many screen-detected invasive breast cancers is to regress spontaneously but the study was possibly confounded by use of hormone replacement therapy in the population. We did a similar analysis of data collected during an earlier period when few women were exposed to hormone replacement therapy.
Methods: We compared cumulative breast cancer incidence in age-matched cohorts of women living in seven Swedish counties before and after the initiation of public mammography screening between 1986 and 1990. Women aged 40-49 years were invited to screening every year and women aged 50-74 years were invited every 2 years. A screened group including all women aged 40-69 years (n=328,927) was followed-up for 6 years after the first invitation to the programme. A control group including all women in the same age range (n=317,404) was also followed-up for 6 years--4 years without screening and 2 years when they entered the screening programme. Screening attendance was much the same in both groups (close to 80%). Counts of incident invasive breast cancers were obtained from the Swedish Cancer Registry (in-situ cancers were excluded).
Findings: Before the age-matched controls were invited to be screened at the end of their follow-up period, the 4-year cumulative incidence of invasive breast cancer was significantly higher in the screened group (982 per 100,000) than it was in the control group (658 per 100,000) (relative risk [RR] 1·49, 95% CI 1·41-1·58). Even after prevalence screening in the control group, the screened group had higher 6-year cumulative incidence of invasive breast cancer (1443 per 100,000 vs 1269 per 100,000; RR 1·14, 1·10-1·18).
Interpretation: Because the cumulative incidence among controls did not reach that of the screened group, we believe that many invasive breast cancers detected by repeated mammography screening do not persist to be detected by screening at the end of 6 years, suggesting that the natural course of many of the screen-detected invasive breast cancers is to spontaneously regress.
Funding: None.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Comment in
-
Regression of screening-detected breast cancer.Lancet Oncol. 2011 Nov;12(12):1083-4. doi: 10.1016/S1470-2045(11)70262-5. Epub 2011 Oct 11. Lancet Oncol. 2011. PMID: 21996167 No abstract available.
Similar articles
-
The natural history of invasive breast cancers detected by screening mammography.Arch Intern Med. 2008 Nov 24;168(21):2311-6. doi: 10.1001/archinte.168.21.2311. Arch Intern Med. 2008. PMID: 19029493
-
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
-
Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.Cancer. 1998 Apr 15;82(8):1521-8. Cancer. 1998. PMID: 9554530 Clinical Trial.
-
Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet. 2002 Mar 16;359(9310):909-19. doi: 10.1016/S0140-6736(02)08020-0. Lancet. 2002. PMID: 11918907 Review.
-
Mammography in symptomatic and asymptomatic patients.Hematol Oncol Clin North Am. 1989 Dec;3(4):611-40. Hematol Oncol Clin North Am. 1989. PMID: 2691492 Review.
Cited by
-
Overdiagnosis in breast cancer chemoprevention trials.Curr Oncol. 2015 Feb;22(1):e6-e10. doi: 10.3747/co.22.2191. Curr Oncol. 2015. PMID: 25684995 Free PMC article. No abstract available.
-
Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.Ann Intern Med. 2022 Jan;175(1):11-19. doi: 10.7326/M20-8076. Epub 2021 Nov 23. Ann Intern Med. 2022. PMID: 34807717 Free PMC article.
-
Options for early breast cancer follow-up in primary and secondary care - a systematic review.BMC Cancer. 2012 Jun 13;12:238. doi: 10.1186/1471-2407-12-238. BMC Cancer. 2012. PMID: 22695275 Free PMC article.
-
Overdiagnosis in screening mammography in Denmark: population based cohort study.BMJ. 2013 Feb 26;346:f1064. doi: 10.1136/bmj.f1064. BMJ. 2013. PMID: 23444414 Free PMC article.
-
Lead-time models should not be used to estimate overdiagnosis in cancer screening.J Gen Intern Med. 2014 Sep;29(9):1283-6. doi: 10.1007/s11606-014-2812-2. Epub 2014 Mar 4. J Gen Intern Med. 2014. PMID: 24590736 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical